News & Updates

Show Multimedia Only

Novel cyclosporine formulation delivers in dry eye disease

06 Feb 2021

Cyclosporine in the form of an ophthalmic gel is safe and effective in the treatment of dry eye disease, according to the results of a phase II trial.

Novel cyclosporine formulation delivers in dry eye disease

06 Feb 2021

Myopic eyes have thinner ganglion cell-inner plexiform layer

06 Feb 2021

The ganglion cell-inner plexiform layer is considerably thinner in myopic eyes, a new China study has found. The deterioration in GCIPL may be an indicator for the progression of myopia.

Myopic eyes have thinner ganglion cell-inner plexiform layer

06 Feb 2021

Continuous aflibercept injections yield better outcomes in neovascular AMD

05 Feb 2021

Continuous treatment with aflibercept leads to better visual outcomes in the long run among patients with neovascular age-related macular degeneration (nAMD), reports a new study.

Continuous aflibercept injections yield better outcomes in neovascular AMD

05 Feb 2021

News & Updates

Showing Ophthalmology articles

Showing

Specialty:

Novel cyclosporine formulation delivers in dry eye disease

Novel cyclosporine formulation delivers in dry eye disease

Myopic eyes have thinner ganglion cell-inner plexiform layer

Myopic eyes have thinner ganglion cell-inner plexiform layer

Continuous aflibercept injections yield better outcomes in neovascular AMD

Continuous aflibercept injections yield better outcomes in neovascular AMD